source name	characteristics[organism]	characteristics[organism part]	characteristics[age]	characteristics[developmental stage]	characteristics[sex]	characteristics[ancestry category]	characteristics[disease]	characteristics[phenotype]	characteristics[biological replicate]	characteristics[cell type]	characteristics[cell line]	characteristics[enrichment process]	assay name	comment[fractionation method]	comment[fraction identifier]	comment[technical replicate]	comment[label]	comment[instrument]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[dissociation method]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[file uri]	comment[data file]	Material Type	factor value[cell line]
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 160	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH11.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH11.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 161	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH3.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH3.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 162	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH4.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH4.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 163	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH5.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH5.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 164	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH6.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH6.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 165	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH8.raw	20120302_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep1_pH8.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 184	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH11.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH11.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 185	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH3.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH3.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 186	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH4.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH4.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 187	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH5.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH5.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 188	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH6.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH6.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 189	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	1	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH8.raw	20120310_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep1_pH8.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 166	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH11.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH11.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 167	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH3.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH3.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 168	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH4.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH4.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 169	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH5.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH5.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 170	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH6.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH6.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 171	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH8.raw	20120303_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep2_pH8.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 190	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH11.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH11.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 191	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH3.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH3.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 192	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH4.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH4.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 193	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH5.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH5.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 194	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH6.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH6.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 195	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	2	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH8.raw	20120313_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep2_pH8.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 172	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH11.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH11.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 173	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH3.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH3.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 174	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH4.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH4.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 175	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH5.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH5.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 176	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH6.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH6.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 177	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH8.raw	20120304_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep3_pH8.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 196	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH11.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH11.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 197	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH3.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH3.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 198	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH4.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH4.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 199	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH5.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH5.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 200	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH6.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH6.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 201	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	3	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH8.raw	20120314_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep3_pH8.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 178	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH11.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH11.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 179	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH3.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH3.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 180	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH4.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH4.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 181	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH5.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH5.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 182	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH6.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH6.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 183	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH8.raw	20120308_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF5_rep4_pH8.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 202	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	1	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH11.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH11.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 203	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	2	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH3.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH3.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 204	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	3	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH4.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH4.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 205	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	4	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH5.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH5.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 206	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	5	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH6.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH6.raw	cell	HeLa-S3
PXD000612-Sample-2	Homo sapiens	cervix	31Y	adult	female	Black	adenocarcinoma	compound: drug EGF	1	epithelial cell	HeLa-S3	no enrichment	run 207	NT=Strong anion-exchange chromatography (SAX);AC=PRIDE:0000558	6	4	AC=MS:1002038;NT=label free sample	AC=MS:1001911;NT=Q Exactive	20 ppm	0.05 Da	AC=MS:1000422;NT=HCD	AC=MS:1001251;NT=Trypsin	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Phospho;MT=Variable;TA=S,T,Y;AC=UNIMOD:21	NT=Deamidated;MT=Variable;TA=N,Q;AC=UNIMOD:7	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2014/08/PXD000612/20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH8.raw	20120317_EXQ5_KiSh_SA_LabelFree_HeLa_Proteome_EGF15_rep4_pH8.raw	cell	HeLa-S3
